| |
 Prostate Cancer Biopsy
 During a prostate cancer biopsy, a sample of tissue is removed in order to perform testing to check for the presence of cancer. During a biopsy, a transrectal ultrasound is used to guide the needle or needles to remove six or more samples from different parts of the prostate. Some physicians may take 12 tissue samples to be sure that no cancerous tissue is missed.
A prostate biopsy is the only way to accurately diagnose prostate cancer. However, although it is the most accurate method in detecting the disease, it is still possible to miss a cancer or receive false results after a biopsy. Prostate cancer does not typically form as one single tumor, but rather made up of many small tumors or cancer cells in different areas of the prostate. It is for this reason, and because the tissues extracted are only a sampling and not a complete composition, prostate cancer is difficult to detect with biopsy needles. If there are other strong indications of prostate cancer, the patient should consider repeating a biopsy if no cancer was found in the results of the original procedure.
A prostate biopsy is normally performed under local anesthesia and is an outpatient procedure, typically not requiring an overnight hospital stay.
Envisioneering Medical focuses resources and technology to develop equipment to aid physicians in detection, diagnosis and treatment. The TargetScan 3D imaging and targeted biopsy system offers the first real advance in prostate imaging and biopsy in over a decade. It eases any discomfort of probing during examination, as once it is place, there is no need for repositioning. The system allows a physician to generate a true solid 3D image, manipulate it, and precisely plan and undertake a multi-sample biopsy of a targeted tissue mass in the prostate. Click to learn more about TargetScan 3D or ask your physician today.
|
|
